feedburner

Enter your email address:

Delivered by FeedBurner

Aurobindo Pharma gets USFDA nod for its expectorant tablets

The company has received final approval from the United States Food
and Drug Administration (USFDA) to manufacture its generic Guaifenesin
extended-release tablets in the strengths of 600 mg and 1,200 mg.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-usfda-nod-for-its-expectorant-tablets/articleshow/71740775.cms



0 comments:

Post a Comment